StonvexLoading…
StonvexStonvexStonvexCore line items from PVH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-01 | Annual 2025 2025-02-02 | Annual 2024 2024-02-04 | Annual 2023 2023-01-29 |
|---|---|---|---|---|
Revenue | $8.95B | $8.65B | $9.22B | $9.02B |
Operating Income | $230.60M | $772.30M | $928.80M | $470.70M |
Net Income | $25.30M | $598.50M | $663.60M | $200.40M |
EPS (Diluted) | $0.52 | $10.56 | $10.76 | $3.03 |
Total Assets | $11.68B | $11.03B | $11.17B | $11.77B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $701.50M | $748.00M | $707.60M | $550.70M |
Free Cash Flow OCF − CapEx | $538.40M | $582.20M | $724.70M | $-250.90M |
Shares Outstanding | 48.50M | 56.70M | 61.70M | 66.20M |